Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Fielding

Showing results (111-120 of 166) with videos related to

Pageof 17
Sort By:
British Journal of Haematology|June 26, 2020
Successful remission induction therapy with gilteritinib in a patient with de novo FLT3-mutated acute myeloid leukaemia and severe COVID-19Andrew J Wilson, Ethan Troy-Barnes, Maryam Subhan, et al.
British Journal of Haematology|January 31, 1998
G-CSF after peripheral blood stem cell transplantation in lymphoma patients significantly accelerated neutrophil recovery and shortened time in hospital: results of a randomized BNLI trialD C Linch, D W Milligan, D A Winfield, et al.
Leukemia & Lymphoma|December 4, 2020
Utility of 18F-FDG-PET/CT in lymphoblastic lymphomaThomas A Fox, Ben Carpenter, Mary Taj, et al.
Blood|April 8, 2010
HLA-mismatched unrelated donors are a viable alternate graft source for allogeneic transplantation following alemtuzumab-based reduced-intensity conditioningAdam J Mead, Kirsty J Thomson, Emma C Morris, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 2, 2012
IGH@ translocations, CRLF2 deregulation, and microdeletions in adolescents and adults with acute lymphoblastic leukemiaAnthony V Moorman, Claire Schwab, Hannah M Ensor, et al.
Blood Advances|December 19, 2023
A robust and validated integrated prognostic index for defining risk groups in adult acute lymphoblastic leukemia: an EWALL collaborative studyAmir Enshaei, Melvin Joy, Ellie Butler, et al.
International Journal of Epidemiology|May 26, 2005
Investigation of the risk factors for tuberculosis: a case-control study in three countries in West AfricaC Lienhardt, K Fielding, J S Sillah, et al.
Bone Marrow Transplantation|January 16, 2013
Evidence for a GVL effect following reduced-intensity allo-SCT in ALL: a British Society of Blood and Marrow Transplantation studyP G Medd, A J Peniket, T J Littlewood, et al.
Leukemia|September 29, 2023
Real-world evaluation of UK high hyperdiploidy profile using a large cohort of patients provided by HARMONY data platformAmir Enshaei, Javier Martinez Elicegui, Esther Anguiano, et al.
British Journal of Haematology|January 9, 2013
Risk-stratified adoptive cellular therapy following allogeneic hematopoietic stem cell transplantation for advanced chronic lymphocytic leukaemiaSimon E Richardson, Iftekhar Khan, Andrew Rawstron, et al.
Pageof 17

Showing results (111-120 of 166) with videos related to

Sort By:
Pageof 17
British Journal of Haematology|June 26, 2020
Successful remission induction therapy with gilteritinib in a patient with de novo FLT3-mutated acute myeloid leukaemia and severe COVID-19Andrew J Wilson, Ethan Troy-Barnes, Maryam Subhan, et al.
British Journal of Haematology|January 31, 1998
G-CSF after peripheral blood stem cell transplantation in lymphoma patients significantly accelerated neutrophil recovery and shortened time in hospital: results of a randomized BNLI trialD C Linch, D W Milligan, D A Winfield, et al.
Leukemia & Lymphoma|December 4, 2020
Utility of 18F-FDG-PET/CT in lymphoblastic lymphomaThomas A Fox, Ben Carpenter, Mary Taj, et al.
Blood|April 8, 2010
HLA-mismatched unrelated donors are a viable alternate graft source for allogeneic transplantation following alemtuzumab-based reduced-intensity conditioningAdam J Mead, Kirsty J Thomson, Emma C Morris, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 2, 2012
IGH@ translocations, CRLF2 deregulation, and microdeletions in adolescents and adults with acute lymphoblastic leukemiaAnthony V Moorman, Claire Schwab, Hannah M Ensor, et al.
Blood Advances|December 19, 2023
A robust and validated integrated prognostic index for defining risk groups in adult acute lymphoblastic leukemia: an EWALL collaborative studyAmir Enshaei, Melvin Joy, Ellie Butler, et al.
International Journal of Epidemiology|May 26, 2005
Investigation of the risk factors for tuberculosis: a case-control study in three countries in West AfricaC Lienhardt, K Fielding, J S Sillah, et al.
Bone Marrow Transplantation|January 16, 2013
Evidence for a GVL effect following reduced-intensity allo-SCT in ALL: a British Society of Blood and Marrow Transplantation studyP G Medd, A J Peniket, T J Littlewood, et al.
Leukemia|September 29, 2023
Real-world evaluation of UK high hyperdiploidy profile using a large cohort of patients provided by HARMONY data platformAmir Enshaei, Javier Martinez Elicegui, Esther Anguiano, et al.
British Journal of Haematology|January 9, 2013
Risk-stratified adoptive cellular therapy following allogeneic hematopoietic stem cell transplantation for advanced chronic lymphocytic leukaemiaSimon E Richardson, Iftekhar Khan, Andrew Rawstron, et al.
Pageof 17